While gaps persist in workforce retention, infrastructure, and equitable access, the transformation of Nigeria’s health ...

The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...

The Food and Drug Administration's top ... Prasad noted that Marks sidelined Office of Vaccines Research Research and Review leaders in 2021 for resisting rushed full approval of COVID vaccines and ...

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...

The U.S. Food and Drug Administration has tapped Dr. Vinay Prasad to lead the agency’s Center for Biologics Evaluation and Research, which oversees vaccines, blood supply, and gene therapies.

Prasad's appointment comes as the FDA plans to require future vaccines to be tested through placebo-controlled trials. Public health officials are also reconsidering recommendations for COVID vacc ...

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...

WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to oversee the agency’s program for vaccines and ...

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...